Mechanistic Insights and Emerging Therapeutic Strategies in Recurrent Pericarditis
References
- Wang TKM, Allan KL, Cremer PC, et al. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2025 Dec 23;86(25):2691–2719. doi: 10.1016/j.jacc.2025.05.023
- Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025 Oct 22;46(40):3952–4041. doi: 10.1093/eurheartj/ehaf192
- Cremer PC, Klein AL, Imazio M. Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review. JAMA. 2024 Oct 1;332(13):1090–1100. doi: 10.1001/jama.2024.12935
- Kumar S, Khubber S, Reyaldeen R, et al. Advances in Imaging and Targeted Therapies for Recurrent Pericarditis: A Review. JAMA Cardiol. 2022 Sep 1;7(9):975–985. doi: 10.1001/jamacardio.2022.2584
- Lopalco G, Rigante D, Catarini L, et al. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment. Trends Cardiovasc Med. 2021 Jul;31(5):265–274. doi: 10.1016/j.tcm.2020.04.006
- Vecchié A, Bonaventura A, Golino M, Thomas G, Abbate A. Novel Therapeutic Insights Into the Treatment of Pericarditis: Targeting the Innate Immune System. J Cardiovasc Pharmacol. 2024 May 1;83(5):377–383. doi: 10.1097/FJC.0000000000001553
- Cacoub P, Marques C. Acute recurrent pericarditis: from pathophysiology towards new treatment strategy. Heart. 2020 Jul;106(14):1046–1051. doi: 10.1136/heartjnl-2019-316481
- Imazio M, Mardigyan V, Andreis A, Franchin L, De Biasio M, Collini V. New Developments in the Management of Recurrent Pericarditis. Can J Cardiol. 2023 Aug;39(8):1103–1110. doi: 10.1016/j.cjca.2023.04.008
- Peet CJ, Rowczenio D, Omoyinmi E, et al. Pericarditis and Autoinflammation: A Clinical and Genetic Analysis of Patients With Idiopathic Recurrent Pericarditis and Monogenic Autoinflammatory Diseases at a National Referral Center. J Am Heart Assoc. 2022 Jun 7;11(11):
e024931 . doi: 10.1161/JAHA.121.024931 - Cantarini L, Lopalco G, Selmi C, et al. Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev. 2015 Feb;14(2):90–7. doi: 10.1016/j.autrev.2014.10.005
- Vecchié A, Del Buono MG, Chiabrando GJ, Dentali F, Abbate A, Bonaventura A. Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease. Curr Cardiol Rep. 2021 Oct 1;23(11):
157 . doi: 10.1007/s11886-021-01589-x - LeWinter MM. Clinical practice. Acute pericarditis. N Engl J Med. 2014 Dec 18;371(25):2410–6. doi: 10.1056/NEJMcp1404070
- Del Buono MG, Vecchié A, Damonte JI, et al. Pericarditis Recurrence After Initial Uncomplicated Clinical Course. Am J Cardiol. 2021 Dec 1;160:112–116. doi: 10.1016/j.amjcard.2021.08.048
- Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013 Sept;26(9):965–1012.e15. doi: 10.1016/j.echo.2013.06.023
- Cremer PC, Kumar A, Kontzias A, et al. Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment. J Am Coll Cardiol. 2016 Nov 29;68(21):2311–2328. doi: 10.1016/j.jacc.2016.07.785
- Collini V, Faletra F, Venturelli F, et al. Prognostic role of genetic variants in recurrent pericarditis. Int J Cardiol. 2025 Nov 15;439:
133621 . doi: 10.1016/j.ijcard.2025.133621 - Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA. 2015 Oct 13;314(14):1498–506. doi: 10.1001/jama.2015.12763
- Klein AL, Wang TKM, Cremer PC, et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC Cardiovasc Imaging. 2024 Aug;17(8):937–988. doi: 10.1016/j.jcmg.2024.04.010
- Tassetti L, Bonomi A, Piccinni G, et al. Pericardial tissue characterization with quantitative methods in cardiac magnetic resonance in acute or recurrent pericarditis. Int J Cardiol. 2025 Nov 15;439:
133607 . doi: 10.1016/j.ijcard.2025.133607 - Hasslacher S, Kritharides L, Yu C, et al. Added value of cardiac magnetic resonance to clinical diagnostic criteria in the diagnosis of pericarditis: a retrospective cohort study. Heart, 2025 Oct 23;heartjnl-2025-326648. doi: 10.1136/heartjnl-2025-326648
- Imazio M, Andreis A, Klein A, Lazaros G, Lazarou E, Collini V. Scores for Risk Stratification of Pericarditis. Curr Cardiol Rep. 2025 Jun 24;27(1):
101 . doi: 10.1007/s11886-025-02259-y - Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013 Oct 17;369(16):1522–8. doi: 10.1056/NEJMoa1208536
- Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011 Oct 4;155(7):409–14. doi: 10.7326/0003-4819-155-7-201110040-00359
- Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet. 2014 Jun 28;383(9936):2232–7. doi: 10.1016/S0140-6736(13)62709-9
- Brucato A, Imazio M, Gattorno M, et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA. 2016 Nov 8;316(18):1906–1912. doi: 10.1001/jama.2016.15826
- Goel A, Bandyopadhyay D, Malik AH, Gupta R, Frishman WH, Aronow WS. Rilonacept and Other Interleukin-1 Inhibitors in the Treatment of Recurrent Pericarditis. Cardiol Rev. 2023 Jul-Aug;31(4):225–229. doi: 10.1097/CRD.0000000000000476
- Imazio M, Lazaros G, Gattorno M, et al. Anti-interleukin-1 agents for pericarditis: a primer for cardiologists. Eur Heart J. 2022 Aug 14;43(31):2946–2957. doi: 10.1093/eurheartj/ehab452
- Thomas GK, Bonaventura A, Vecchié A, et al. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives. J Cardiovasc Pharmacol. 2024 Jun 1;83(6):503–510. doi: 10.1097/FJC.0000000000001435
- Klein AL, Lin D, Cremer PC, et al. Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial. Heart. 2020 Nov 23;107(6):488–96. doi: 10.1136/heartjnl-2020-317928
- Klein AL, Imazio M, Cremer P, et al. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med. 2021 Jan 7;384(1):31–41. doi: 10.1056/NEJMoa2027892
- Saraswati U, Bhalla JS, Tereshchenko LG, et al. Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis. Heart. 2025 Oct 20;heartjnl-2024-325515. doi: 10.1136/heartjnl-2024-325515
- Cremer PC, Luis SA, Garshick MS, et al. IL-1 Pathway Inhibition in Recurrent Pericarditis Management: Real-World Adoption of Corticosteroid Sparing in RESONANCE. JACC Adv. 2025 Sep;4(9) : p.
102050 . doi: 10.1016/j.jacadv.2025.102050 - Myachikova VY, Maslyanskiy AL, Moiseeva OM, et al. Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results. J Am Coll Cardiol. 2023 Jul 4;82(1):30–40. doi: 10.1016/j.jacc.2023.04.046
- Lo Presti S, Elajami TK, Reyaldeen R, Anthony C, Imazio M, Klein AL. Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors. J Am Heart Assoc. 2021 Oct 5;10(19):
e021685 . doi: 10.1161/JAHA.121.021685 - Al-Kazaz M, Klein AL, Oh JK, et al. Pericardial Diseases and Best Practices for Pericardiectomy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Aug 6;84(6):561–580. doi: 10.1016/j.jacc.2024.05.048
- Khandaker MH, Schaff HV, Greason KL, et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin Proc. 2012 Nov;87(11):1062–70. doi: 10.1016/j.mayocp.2012.05.024
- Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. 2025 Sep 29;S0735–1097(25)07555-2. doi: 10.1016/j.jacc.2025.08.047
- Vecchié A, Del Buono MG, Mauro AG, et al. Advances in pharmacotherapy for acute and recurrent pericarditis. Expert Opin Pharmacother. 2022 Apr;23(6):681–691. doi: 10.1080/14656566.2022.2054327
- Peiffer-Smadja N, Domont F, Saadoun D, Cacoub P. Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis. Autoimmun Rev. 2019 Jun;18(6):621–626. doi: 10.1016/j.autrev.2019.04.001
- ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026.
CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation (MAVERIC) ; 2025 Oct 2 [cited 2026 Jan 21]. Available from:https://clinicaltrials.gov/study/NCT06708299 - ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026.
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis ; 2026 Jan 21 [cited 2026 Jan 28]. Available from:https://clinicaltrials.gov/study/NCT06836232 - ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026.
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis ; 2026 Jan 21 [cited 2026 Jan 28]. Available from:https://clinicaltrials.gov/study/NCT07010159
DOI: https://doi.org/10.14797/mdcvj.1760 | Journal eISSN: 1947-6108
Language: English
Page range: 4 - 13
Submitted on: Dec 12, 2025
Accepted on: Jan 14, 2026
Published on: Mar 10, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2026 Mohammad A. Alqahtani, Tom Kai Ming Wang, Allan L. Klein, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.